Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Zainaba Mohamed"'
Autor:
Jan Idkowiak, Suma Uday, Sabba Elhag, Timothy Barrett, Renuka Dias, Melanie Kershaw, Zainaba Mohamed, Vrinda Saraff, Ruth E. Krone
Publikováno v:
Frontiers in Clinical Diabetes and Healthcare, Vol 4 (2023)
IntroductionLanguage barriers can pose a significant hurdle to successfully educating children and young people with type 1 diabetes (CYPD) and their families, potentially influencing their glycaemic control.MethodsRetrospective case-control study as
Externí odkaz:
https://doaj.org/article/7441c4af68a94f9c907f49f469e81a8a
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Adrenal insufficiency encompasses a group of congenital and acquired disorders that lead to inadequate steroid production by the adrenal glands, mainly glucocorticoids, mineralocorticoids and androgens. These may be associated with other hormone defi
Externí odkaz:
https://doaj.org/article/99e591fbe498437aa4ef5679726a3553
Autor:
David J. Bunyan, Evelien Gevers, James I. Hobbs, Philippa J. Duncan-Flavell, Rachel J. Howarth, Muriel Holder-Espinasse, Philippe Klee, Roxane Van-Heurk, Laure Lemmens, Maria Teresa Carminho-Rodrigues, Zainaba Mohamed, Aruna Goturu, Claire R. Hughes, Michal Ajzensztejn, N. Simon Thomas
Publikováno v:
Egyptian Journal of Medical Human Genetics, Vol 22, Iss 1, Pp 1-9 (2021)
Abstract Background Transcriptional regulation of the SHOX gene is highly complex. Much of our understanding has come from the study of copy number changes of conserved non-coding sequences both upstream and downstream of the gene. Downstream deletio
Externí odkaz:
https://doaj.org/article/3e92f1e1c41c4fc8bfbb3cd6724d9103
Autor:
Sophie G Kellaway, Karolina Mosinska, Zainaba Mohamed, Alexander Ryan, Stephen Richardson, Melanie Newbould, Indraneel Banerjee, Mark J Dunne, Karen E Cosgrove
Publikováno v:
PLoS ONE, Vol 14, Iss 10, p e0223999 (2019)
[This corrects the article DOI: 10.1371/journal.pone.0222350.].
Externí odkaz:
https://doaj.org/article/462d6d03ce0941a8914ea06fd78fc76f
Autor:
Sophie G Kellaway, Karolina Mosinska, Zainaba Mohamed, Alexander Ryan, Stephen Richardson, Melanie Newbould, Indraneel Banerjee, Mark J Dunne, Karen E Cosgrove
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0222350 (2019)
Congenital hyperinsulinism (CHI) is characterised by inappropriate insulin secretion causing profound hypoglycaemia and brain damage if inadequately controlled. Pancreatic tissue isolated from patients with diffuse CHI shows abnormal proliferation ra
Externí odkaz:
https://doaj.org/article/ac9e4dea76914cc4b864d4487b65b226
Autor:
Abhidhamma Kaninde, Janki Kotak, Louise Collins, Lesley Drummond, John Pemberton, Jan Idkowiak, Zainaba Mohamed, Renuka Dias, Vrinda Saraff, Melanie Kershaw, Ruth Krone
Publikováno v:
Endocrine Abstracts.
Autor:
Ruchi Nadar, Rajesh Sakremath, Jeremy Kirk, Tabitha Randell, Helen Jenkinson, Helen Woodman, Vrinda Saraff, Zainaba Mohamed
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Endocrine Abstracts.
Autor:
Baranowski Elizabeth S., Eleanor Harding, Susanne A. Gatz, Liam McCarthy, Harish Chandran, Caroline Godber, Louise Denvir, Jenny Turnbull, Jan Idkowiak, Tabitha Randell, Zainaba Mohamed
Publikováno v:
Endocrine Abstracts.
Autor:
Sophie Hambleton, Caroline A Steele, Zainaba Mohamed, John N. S. Matthews, Tim Cheetham, Tim Barratt, Simon H. S. Pearce, Jonathan Prichard, Gillian Watson, Amanda J. Drake, Justin H Davies, Michael Cole, Mario Abinun, Robert D Murray, Nicola Zammitt, Amit Allahabadia, Paul Dimitri, Sonya Carnell
Publikováno v:
Cheetham, T, Cole, M, Abinun, M, Allahabadia, A, Barratt, T, Davies, J H, Dimitri, P, Drake, A, Mohamed, Z, Murray, R D, Steele, C, Zammitt, N, Carnell, S, Prichard, J, Watson, G, Hambleton, S, Matthews, J N S & Pearce, S H S 2021, ' Adjuvant Rituximab – exploratory trial in young people with Graves’ disease ', Journal of Clinical Endocrinology & Metabolism . https://doi.org/10.1210/clinem/dgab763
Context Remission rates in young people with Graves hyperthyroidism are less than 25% after 2 years of thionamide antithyroid drug (ATD). Objective We explored whether rituximab (RTX), a B-lymphocyte–depleting agent, would increase remission rates